Resources & Insights

Virtual trials, COVID-19, & the future

As the FDA continues to develop evolving guidelines, our industry has experienced a sudden, paradigm shift towards hybrid and virtual trials, with telemedicine becoming the “norm” for patient interaction across a variety of therapeutic areas.

April 21, 2020
View the Post

COVID-19: Update from PharPoint Research

As the situation with COVID-19 evolves, the PharPoint Research team is taking necessary precautions to ensure study operations continue uninterrupted. During this critical time in our industry, PharPoint remains fully dedicated, as always, to helping clients improve global health.

March 16, 2020
View the Post

Acknowledging Rare Disease Day 2020

This February 29th, PharPoint acknowledges Rare Disease Day. We are relentless in supporting clients so that they may advance rare disease research and the approval of breakthrough treatments.

February 27, 2020
View the Post

How to Perform non-eCRF Data Reconciliation

How do you perform non-eCRF data (ECG, Labs, PK) reconciliation in EDC platforms like Medrio? A PharPoint clinical trial expert answers as part of our #askaclinicaltrialexpert blog series.

January 9, 2020
View the Post

Choosing an EDC Provider: Ask a CRO Series

For our upcoming study, we know we want to use EDC—but there are so many options. How should we choose an EDC provider? As part of our Ask a Clinical Trial Expert blog series, a PharPoint clinical trial expert answers.

January 9, 2020
View the Post

Clinical Trial Study Rescue: Ask a CRO

Are you worried that the service providers working on your study are causing it to fall behind? Don’t fret: there are options available to get your study back on track.

October 9, 2019
View the Post

Bridging the the gap between sponsors and service providers

What challenges exist between CROs and Sponsors—and is collaborative technology the answer, or something else?

October 9, 2019
View the Post

Adaptive Trial Design and the CRO Landscape

Learn more about the shifting CRO landscape, as PharPoint’s manager of programming technologies discusses adaptive trial design and outsourcing with EDC provider Medrio.

October 9, 2019
View the Post

Turn Therapeutics featured on WorldWide Business with kathy ireland

Last October, Turn Therapeutics was featured on Worldwide Business with kathy ireland®, where Turn founder and CEO Bradley Burnam shared his unique story of what makes Turn Therapeutics product different. PharPoint Research is proud to have worked with the Turn Therapeutics team as they continue to improve the lives and treatment options for patients of infectious disease.

October 1, 2019
View the Post

How and When to Consider a Data Monitoring Committee

How and when should you consider a DMC (also known as a DSMB, DSMC, or IDMC)? Learn more in this brief video.

October 9, 2016
View the Post